论文部分内容阅读
目的探讨新生儿高胆红素血症临床治疗效果。方法选取新生儿高胆红素血症72例,随机分为对照组(36)与治疗组(36),对照组采取西医常规治疗,治疗组在对照组基础上采用金双歧联合茵栀黄口服液治疗,对比两组临床效果。结果治疗组胆红素水平为(112.21±13.26)μmol/L,对照组为(154.56±15.87)μmol/L,治疗组明显低于对照组(P<0.05)。治疗组总有效率为94.44%,对照组为72.22%,治疗组明显高于对照组(P<0.05)。结论对于新生儿高胆红素血症采用金双歧联合茵栀黄口服液治疗,安全有效,具有临床应用价值。
Objective To investigate the clinical effect of neonatal hyperbilirubinemia. Methods 72 cases of neonatal hyperbilirubinemia were randomly divided into control group (36) and treatment group (36). The control group was treated with conventional western medicine. The treatment group was treated with Jinshuangqi Yinzhihuang oral liquid Treatment, compared two groups of clinical results. Results The level of bilirubin in the treatment group was (112.21 ± 13.26) μmol / L and that in the control group was (154.56 ± 15.87) μmol / L, which was significantly lower in the treatment group than in the control group (P <0.05). The total effective rate was 94.44% in the treatment group and 72.22% in the control group, which was significantly higher in the treatment group than in the control group (P <0.05). Conclusions The neonatal hyperbilirubinemia with Jinshuangqi Yinzhihuang oral liquid treatment is safe and effective, and has clinical value.